AI
By
Bristol Myers Squibb Unveils “Mosaic” AI Content Hub in Mumbai, Advancing Tech-Enabled Patient Engagement
Mumbai, India Bristol Myers Squibb (BMS) today announced the launch of Mosaic, a new artificial intelligence–enabled content hub…
Endpoints Signal Report Finds Nearly Half of Biopharma Professionals Are Heavy AI Users, With Expectations of Major R&D Transformation Ahead
Based on Endpoints Signal Pulse Report | December 2025 A new Signal Pulse Report from Endpoints News reveals…
Chai Discovery Becomes Newest AI Unicorn Following $130 Million Series B Financing
Company valued at $1.3 billion as investors back AI-native drug discovery platform San Francisco, California Chai Discovery today…
PhaseV Reports Breakthrough Year in 2025, Marking Transition to Scaled AI Deployment in Clinical Development
Boston, Massachusetts PhaseV announced today that 2025 marked a defining year for the company, highlighted by record revenue…
Are Galux and Boehringer Ingelheim Pioneering AI in Precision Protein Design?
December 17, 2025 — Galux, a South Korean biotech company focused on AI-driven protein therapeutics, has entered a…
Inductive Bio and Amgen Collaborate With ARPA-H to Advance AI-Based Alternatives to Animal Toxicology Testing
United States Inductive Bio, a New York–based artificial intelligence company focused on drug discovery, has been awarded up…
